Ivermectin / Pyrantel Tablets

Verify with FDA CVM →

633 adverse event reports submitted to the FDA

Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
633
Total Reports
32
Deaths Reported
510.0%
Death Rate

Active Ingredients

Ivermectin / Pyrantel Tablets

Administration Routes

OralUnknownOropharyngealTopical

Species Affected

Dog 623
Unknown 9
Human 1

Most Affected Breeds

Crossbred Canine/dog 195
Retriever - Labrador 51
Retriever - Golden 34
Shepherd Dog - German 23
Shepherd Dog - Australian 19
Shih Tzu 17
Terrier - Yorkshire 14
Pit Bull 13
Terrier (unspecified) 13
Boxer (German Boxer) 12

Most Reported Reactions

Vomiting 186
Emesis (multiple) 81
Lack of efficacy (endoparasite) - heartworm 76
Lethargy (see also Central nervous system depression in 'Neurological') 66
Diarrhoea 60
Seizure NOS 57
Ataxia 27
Death by euthanasia 22
INEFFECTIVE, HOOKS 22
Anorexia 20
Other abnormal test result NOS 19
Bloody diarrhoea 16

Outcome Breakdown

Recovered/Normal
288 (46.2%)
Ongoing
246 (39.4%)
Outcome Unknown
45 (7.2%)
Euthanized
22 (3.5%)
Recovered with Sequela
13 (2.1%)
Died
10 (1.6%)

Data Summary

Metric Value
Total adverse event reports 633
Reports involving death 32
Case-fatality rate (reported events) 510.0%
Distinct species in reports 3
Distinct breeds in reports 20
Distinct reactions reported 20
Active ingredients on file 1

Source: FDA Center for Veterinary Medicine — Adverse Event Reporting (CVM AER). Counts reflect voluntary reports only.

Ivermectin / Pyrantel Tablets Adverse Event Insights

The FDA Center for Veterinary Medicine database currently holds 633 adverse event reports referencing Ivermectin / Pyrantel Tablets, including 32 reports in which the animal died — a 510.0% case-fatality figure among reported events only, not a population-level mortality rate. Active ingredient on file: Ivermectin / Pyrantel Tablets. Reported administration routes include Oral, Unknown, Oropharyngeal, Topical. These numbers reflect voluntary submissions from pet owners, veterinarians, and manufacturers and therefore under-represent mild events and over-represent severe ones — a pattern the FDA has documented repeatedly for pharmacovigilance datasets.

The species most frequently named in Ivermectin / Pyrantel Tablets reports are Dog (623 reports), Unknown (9 reports), Human (1 reports), with Dog accounting for the largest share. Within those species, Crossbred Canine/dog (195), Retriever - Labrador (51), Retriever - Golden (34) appear most often — though breed popularity and ownership density shape these counts as much as any drug-specific sensitivity. This distribution matters because the same active ingredient can behave very differently across body sizes, ages, and species physiology.

The most commonly reported clinical signs associated with Ivermectin / Pyrantel Tablets are Vomiting (186), Emesis (multiple) (81), Lack of efficacy (endoparasite) - heartworm (76), Lethargy (see also Central nervous system depression in 'Neurological') (66). Of the 624 reports with a coded outcome, Recovered/Normal is the leading category at 46.2%. Because FDA adverse event data describes correlation rather than causation, these figures are best used to frame informed questions with a veterinarian and to compare reporting patterns across related products — not as a standalone safety verdict on Ivermectin / Pyrantel Tablets.

Source: FDA Center for Veterinary Medicine — Adverse Event Reports FDA Center for Veterinary Medicine — Adverse Event Reports Data reflects voluntary submissions and may not represent actual incidence rates

Related

Data sourced from official AKC, AVMA, ACVO, and breed-club veterinary references. See our methodology for details. Retrieved and formatted by PlainBreed Editorial